Life Science REIT has launched a strategic review that could see it sold or wound down, with several buyers already showing interest in buying the company.
The company said in a stock exchange announcement that the review, led by Panmure
Life Science REIT has launched a strategic review that could see it sold or wound down, with several buyers already showing interest in buying the company.
The company said in a stock exchange announcement that the review, led by Panmure